Translate
Stoke Therapeutics, Inc.
About
29.34USD-0.33 -1.11%
Closed • Updated at 13:19 GMT+00:00Market Cap$1.83B
Volume682.8K
Beta0.94
RSI33.81
Gross Margin87.07%
Stoke Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
Apr 30 2026
Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates
Apr 14 2026
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Apr 8 2026
Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr 7 2026
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors
Recent Videos
Stoke Therapeutics' Breakthrough in Dravet Syndrome Treatment!
May 06, 2026
An experimental treatment for Dravet gained attention when phase 1/2 data was published in NEJM.
Apr 07, 2026
How to Invest in Stoke Therapeutics Inc (STOK) Step by Step
Mar 23, 2026
Comprar acciones de Stoke Therapeutics Inc: guía rápida (STOK)
Mar 17, 2026
Community Chat
Ask AI
Try asking